Downloads
Revenue

Description

The American Association for Bronchology and Interventional Pulmonology is excited to release it's redesigned new I-PASS app (Interventional Pulmonology Application for Self-Study) as a replacement to the previous KAT app. This app is specifically designed to challenge and improve your knowledge in the field of interventional pulmonary through the use of case based questions, explanations, and suggested readings. Whether you are preparing for the IP board, the CAQ exam, are just beginning a career in interventional pulmonology, or simply want to refresh and expand your knowledge, this app is for you! The app contains 200 questions on many timely testing topics. Purchasing the app will provide access to the entire library for one year. At the current time CME credit is not available.
You need to get the subscription to access the content of this application. A purchase amount of $200 yearly will be applied to your iTunes account on confirmation. Subscriptions will automatically renew unless canceled within 24-hours before the end of the current period. You can cancel anytime with your iTunes account settings. Any unused portion of a free trial will be forfeited if you purchase a subscription. For more information, see our ToS(https://aabronchology.org/terms-of-use/) and Privacy Policy(https://aabronchology.org/about/privacy-policy/).
Hide.. Show more..

In-Apps

Annual Subscription
219,99 €

Screenshots

User Rating
App is not rated in Spain yet.
Ratings History

AABIP iPASS Installs

Last 30 days

AABIP iPASS Revenue

Last 30 days

AABIP iPASS Reviews

No Reviews in Spain
App doesn't have any reviews in Spain yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Keywords

AABIP iPASS Competitors

AABIP iPASS Revenue and Downloads

Gain valuable insights into AABIP iPASS performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Languages
English
Recent version
1.6 (11 months ago )
Released on
Dec 2, 2020 (3 years ago )
Last updated
3 weeks ago